“…In total, 19 different cultured viruses were evaluated. Four SARS-CoV-2 isolates from Korea (wild-type, alpha variant, beta variant, and delta variant), human coronavirus NL63 (Korea/CN0601/14), human coronavirus 229E (Korea/KUMC-9), human coronavirus OC43 (KBPV-VR-8), and MERS-CoV (MERS-CoV/KOR/KNIH/002_05_2015) were obtained from the Korea Centers for Disease Control and Prevention (KCDC, Republic of Korea), and other viruses, including porcine epidemic diarrhea virus (Korea/SM98), dengue virus type 2 (Korea/DENV-2/KBPV-VR-29), human H3N2 influenza A virus (Korea/37/2012), human H1N1 influenza A virus (California/04/09), human influenza B virus (B/Brisbane/60/2008), parainfluenza virus 1 (Korea/KUMC-44), human respiratory syncytial virus (HRSV-A/IC688/12), and adenovirus type 3 (KUMC-62), were obtained from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) or purchased from the Korea Bank for Pathogenic Viruses (Republic of Korea) [ 23 ]. RNA from SARS-CoV (HKU-39849) was provided by Dr. Seungtaek Kim (Institute Pasteur Korea) [ 24 ], and viral RNA samples from bat-derived SARS-related CoV (GenBank accession numbers: MK991935 and MK991936) from bat fecal samples, which were used in specificity assays (Table 2 ), were provided by Prof. Hye Kwon Kim (Chungbuk National University, South Korea) [ 25 ].…”